HomeInsights52 Week High Stocks

Bliss Gvs Pharma Ltd 52 Week High

Bliss Gvs Pharma Ltd 52 Week High

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

19.8 K

stocks traded

Last Updated time: 05 Nov 14:05 PM

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

YEARHIGH

148.95

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week HIGH of Bliss GVS Pharma Ltd is ₹ 148.95 as of 04 Nov 24.

Company Fundamentals for Bliss GVS Pharma Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 2024124.25
01 Nov 2024126.9
31 Oct 2024123.4
30 Oct 2024125.95
29 Oct 2024123.65
28 Oct 2024117.95
25 Oct 2024108.65
24 Oct 2024124.3
23 Oct 2024126.75
22 Oct 2024124.75

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

18 Oct 202410:48

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

04 Oct 202418:37

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 202411:35

News

Bliss GVS Pharma to convene AGM

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will b...

Read more

04 May 202416:04

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

03 May 202410:36

News

Bliss GVS Pharma announces board meeting date

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 202...

Read more

26 Apr 202411:02

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Bliss GVS Pharma Ltd

What is the significance of Bliss GVS Pharma Ltd reaching its 52-week high?

Bliss GVS Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Bliss GVS Pharma Ltd 52-week high?

Investors monitor Bliss GVS Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Bliss GVS Pharma Ltd a good buy when it hits its 52-week high?

Whether Bliss GVS Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Bliss GVS Pharma Ltd fundamentals.

What should I consider before investing in Bliss GVS Pharma Ltd at its 52-week high?

Before investing in Bliss GVS Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Bliss GVS Pharma Ltd stock price continue to rise after reaching its 52-week high?

Bliss GVS Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*